Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Agid

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Schizophrenia Research|March 1, 2017
Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysisHiroyoshi Takeuchi, Sadhana Thiyanavadivel, Ofer Agid, et al.
JAMA Psychiatry|March 7, 2014
Schizophrenia, cognition, and psychosisGary Remington, George Foussias, Gagan Fervaha, et al.
Journal of Psychiatric Research|February 11, 2014
Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment toolGagan Fervaha, Ofer Agid, George Foussias, et al.
Schizophrenia Research|March 3, 2020
You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medicationRobert B Zipursky, Gbolahan Odejayi, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 15, 2024
Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Corrélats cliniques des concentrations plasmiques de palipéridone à libération prolongéeRobert B Zipursky, Ofer Agid, Michael Kiang, et al.
Archives of General Psychiatry|December 10, 2003
Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejectedOfer Agid, Shitij Kapur, Tamara Arenovich, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
Pharmacological mechanisms of T3 augmentation of antidepressant actionMichael E. Newman, Ofer Agid, Eitan Gur, et al.
CNS Spectrums|April 30, 2024
Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorderRoger S McIntyre, Ofer Agid, Egbert Biesheuvel, et al.
Journal of Psychiatric Research|June 20, 2016
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)Hiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 15, 2014
Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE studyGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Schizophrenia Research|March 1, 2017
Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysisHiroyoshi Takeuchi, Sadhana Thiyanavadivel, Ofer Agid, et al.
JAMA Psychiatry|March 7, 2014
Schizophrenia, cognition, and psychosisGary Remington, George Foussias, Gagan Fervaha, et al.
Journal of Psychiatric Research|February 11, 2014
Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment toolGagan Fervaha, Ofer Agid, George Foussias, et al.
Schizophrenia Research|March 3, 2020
You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medicationRobert B Zipursky, Gbolahan Odejayi, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 15, 2024
Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Corrélats cliniques des concentrations plasmiques de palipéridone à libération prolongéeRobert B Zipursky, Ofer Agid, Michael Kiang, et al.
Archives of General Psychiatry|December 10, 2003
Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejectedOfer Agid, Shitij Kapur, Tamara Arenovich, et al.
The International Journal of Neuropsychopharmacology|May 10, 2001
Pharmacological mechanisms of T3 augmentation of antidepressant actionMichael E. Newman, Ofer Agid, Eitan Gur, et al.
CNS Spectrums|April 30, 2024
Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorderRoger S McIntyre, Ofer Agid, Egbert Biesheuvel, et al.
Journal of Psychiatric Research|June 20, 2016
A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD)Hiroyoshi Takeuchi, Gagan Fervaha, Jimmy Lee, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 15, 2014
Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE studyGagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
Pageof 13